Xiamen Kingdomway Group Overview

  • Year Founded
  • 1997

Year Founded

  • Status
  • Public

  • Employees
  • 2,126


  • Stock Symbol
  • 002626

Stock Symbol

  • Investments
  • 9

  • Share Price
  • $2.12
  • (As of Friday Closing)

Xiamen Kingdomway Group General Information


Xiamen Kingdomway Group Co is a China-based company mainly engaged in the development and innovation of nutrition enhancer and bio-medical products. The company's main products are Coenzyme Q10, microalgae DHA, plant ARA, vitamin A, and vitamin D3.

Contact Information

Ownership Status
Publicly Held
Financing Status
Primary Industry
Stock Exchange
Corporate Office
  • Number 299, Yangguang West Road
  • Haicang District
  • Xiamen, 361022
  • China
+86 0592 000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Xiamen Kingdomway Group Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.12 $2.15 $1.50 - $2.80 $1.29B 610M 9.8M $0.06

Xiamen Kingdomway Group Financials Summary

In Thousands,
TTM 31-Mar-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 1,334,050 1,412,903 1,894,457 3,127,014
Revenue 427,277 438,535 446,835 560,030
EBITDA 46,008 79,616 80,425 175,487
Net Income 36,438 39,112 38,220 122,169
Total Assets 781,477 755,211 786,361 917,430
Total Debt 148,675 126,130 156,444 175,562
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Xiamen Kingdomway Group Patents

Xiamen Kingdomway Group Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240002891-A1 Processes for producing reduced coenzyme q10 Pending 25-May-2023 00000000
US-20230203545-A1 Method for controlled production of glyceric acid Pending 24-Dec-2021 00000000 0
US-20230200419-A1 Method for preparing modified starch, liposome and method for preparing liposome Pending 23-Dec-2021 0000000000
US-20230067269-A1 Anti-aging drug combination and use thereof Pending 30-Aug-2021 0000000000
US-20220304948-A1 Vitamin k2 microcapsule, preparation method thereof and use thereof in manufacture of medicament for preventing or treating cardiovascular and cerebrovascular diseases Pending 28-Sep-2020 A61K31/122
To view Xiamen Kingdomway Group’s complete patent history, request access »

Xiamen Kingdomway Group Executive Team (4)

Name Title Board Seat Contact Info
Yan Hong Chief Financial Officer, Board Secretary & Vice President
Hang Hong Chief Financial Officer, Finance & Board Member
Ma Guoqing Deputy General Manager
Bin Jiang Chairman & Board Member
To view Xiamen Kingdomway Group’s complete executive team members history, request access »

Xiamen Kingdomway Group Board Members (3)

Name Representing Role Since
000 00000 Xiamen Kingdomway Group Chairman & Board Member 000 0000
0000 0000 Xiamen Kingdomway Group Chief Financial Officer, Finance & Board Member 000 0000
0000 0000000 Xiamen Kingdomway Group Vice Chairman of the board 000 0000
To view Xiamen Kingdomway Group’s complete board members history, request access »

Xiamen Kingdomway Group Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Xiamen Kingdomway Group Investments & Acquisitions (9)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Beijing Huaguan Biotechnology 19-Aug-2021 00000 0000 Drug Discovery
Joy Pony 01-Jul-2020 00000 0000 Educational and Training Services (B2C)
Zipfizz 01-Aug-2018 0000000000 0000 Beverages
ProSupps 01-Aug-2016 0000000000 Other Consumer Non-Durables
Doctor's Best 15-Jun-2016 Secondary Transaction - Private Pharmaceuticals
You’re viewing 5 of 9 investments and acquisitions. Get the full list »

Xiamen Kingdomway Group Subsidiaries (3)

Company Name Industry Location Founded
ProSupps Other Consumer Non-Durables Plano, TX 2004
Zipfizz Beverages Woodinville, WA 0000
Doctor's Best Pharmaceuticals Tustin, CA 0000
To view Xiamen Kingdomway Group’s complete subsidiaries history, request access »

Xiamen Kingdomway Group ESG

Risk Overview

Risk Rating

Updated December, 01, 2023

34.35 | High Risk

Risk Scale

A lower score indicates better sustainability












Exposure refers to the extent to which a company is exposed to different material ESG issues



Management is related to actions taken to manage ESG issues


Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.


Covered Companies

00 of 16,421






00 of 928






00 of 456




To view Xiamen Kingdomway Group’s complete esg history, request access »

Xiamen Kingdomway Group FAQs

  • When was Xiamen Kingdomway Group founded?

    Xiamen Kingdomway Group was founded in 1997.

  • Where is Xiamen Kingdomway Group headquartered?

    Xiamen Kingdomway Group is headquartered in Xiamen, China.

  • What is the size of Xiamen Kingdomway Group?

    Xiamen Kingdomway Group has 2,126 total employees.

  • What industry is Xiamen Kingdomway Group in?

    Xiamen Kingdomway Group’s primary industry is Biotechnology.

  • Is Xiamen Kingdomway Group a private or public company?

    Xiamen Kingdomway Group is a Public company.

  • What is Xiamen Kingdomway Group’s stock symbol?

    The ticker symbol for Xiamen Kingdomway Group is 002626.

  • What is the current stock price of Xiamen Kingdomway Group?

    As of 24-May-2024 the stock price of Xiamen Kingdomway Group is $2.12.

  • What is the current market cap of Xiamen Kingdomway Group?

    The current market capitalization of Xiamen Kingdomway Group is $1.29B.

  • What is Xiamen Kingdomway Group’s current revenue?

    The trailing twelve month revenue for Xiamen Kingdomway Group is $427M.

  • What is Xiamen Kingdomway Group’s annual earnings per share (EPS)?

    Xiamen Kingdomway Group’s EPS for 12 months was $0.06.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »